Company intelligence / Profile preview

Elkem

Ownership: Private
Employees: ~7200
Development stage: Other

Overview

Elkem does not conduct clinical trials but supplies high-purity silicone materials that meet stringent regulatory standards for use in approved medical devices. Their Silbione® Biomedical range supports FDA Master Access Files and Drug Master Files.

Therapeutic areas: DermatologyCardiovascularOther
Modalities: DevicePolymer-based material
Industry: Chemicals & Materials

Partnerships

Member of South Carolina Biotechnology Innovation Organization (SCBIO)

Beyond the preview

Go deeper on Elkem.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Elkem.

Explore the full profile